Abciximab (c7E3 fab, ReoPro) with reduced heparin dosing during coronary intervention: Final results of the EPILOG trial

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Lincoff, AM; Tcheng, JE; Califf, RM; Cabot, CF; Miller, DP; Booth, JE; Montague, EA; Anderson, KM; Topol, EJ

Published Date

  • February 1, 1997

Published In

Volume / Issue

  • 29 / 2

Start / End Page

  • 7396 - 7396

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0735-1097

Language

  • English